Results 51 to 60 of about 103,911 (198)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To assess propafenone antiarrhythmic efficacy and optimal timing of the drug administration for relief of persistent atrial fibrillation (PAF). Material and methods.
R. D. Kurbanov   +2 more
doaj   +3 more sources

High beat-to-beat blood pressure variability in atrial fibrillation compared to sinus rhythm

open access: yesBlood Pressure, 2018
Purpose: Atrial fibrillation (AF) is associated with an increased risk for cardiovascular morbidity and mortality, not entirely explained by thromboembolism. The underlying mechanisms for this association are largely unknown.
Joakim Olbers   +5 more
doaj   +1 more source

data of patients heart failure in sinus rhythm [PDF]

open access: yes, 2019
A total of 264 patients were selected from patients with chronic heart failure in sinus rhythm hospitalized in Renmin Hospital from September 2016 to December 2018.
Tang, Q (via Mendeley Data)
core   +1 more source

Low-Dose Amiodarone for Maintenance of Sinus Rhythm After Cardioversion of Atrial Fibrillation or Flutter [PDF]

open access: yes, 1992
Objective.-To study efficacy and safety of low-dose amiodarone for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation or flutter. Design.-Nonrandomized trial; mean duration of follow-up, 20.7 months.
Crijns, Harry J.G.M.   +5 more
core   +1 more source

THE BEHAVIOR OF ATRIO–VENTRICULAR NODAL RHYTHM FOLLOWING DIRECT PERFUSION OF THE SINUS NODE [PDF]

open access: yes, 1966
Direct perfusion of the canine sinus node with various pharmacological agents having negative chronotropic effects commonly leads either to abrupt sinus arrest or to a gradual transition from sinus to atrio–ventricular (A–V) nodal rhythm with ...
T. N. James, R. A. Nadeau
core   +1 more source

Post-operative left atrial volume index is a predictor of the occurrence of permanent atrial fibrillation after mitral valve surgery in patients who undergo mitral valve surgery

open access: yesCardiovascular Ultrasound, 2018
Background Atrial fibrillation (AF) can occur even after the correction of mitral valve (MV) pathology in patients who have pre-operative sinus rhythm and undergo MV surgery.
Min-Kyung Kang   +9 more
doaj   +1 more source

RNAseq shows an all-pervasive day-night rhythm in the transcriptome of the pacemaker of the heart

open access: yesScientific Reports, 2021
Physiological systems vary in a day-night manner anticipating increased demand at a particular time. Heart is no exception. Cardiac output is primarily determined by heart rate and unsurprisingly this varies in a day-night manner and is higher during the
Yanwen Wang   +5 more
doaj   +1 more source

Up‐titration of medication in patients with new‐onset heart failure with and without atrial fibrillation

open access: yesESC Heart Failure
Aims Differences in guideline‐directed medical therapy (GDMT) and clinical outcomes have been observed between heart failure (HF) patients with atrial fibrillation (AF) versus those in sinus rhythm.
Arietje J.L. Zandijk   +6 more
doaj   +1 more source

Instantly Converting Atrial Fibrillation into Sinus Rhythm by a Digital Rectal Exam on a 29-year-Old Male

open access: yesClinical Medicine Insights: Case Reports, 2010
Vagal maneuvers cause increase in vagal tone, which has been shown to slow many types supraventricular tachycardia, such as atrial fibrillation (AF). However, the conversion of AF to sinus rhythm is usually not associated with vagal manuvers. Thus, AF is
Cheng-Huai Ruan
doaj   +1 more source

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS

open access: yesРациональная фармакотерапия в кардиологии, 2015
Aim. To study the changes of plasma levels of NT-proBNP and NT-proANP in patients with persistent atrial fibrillation (AF) treated with various antiarrhythmic drugs.Material and methods.
V. I. Podzolkov   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy